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Abstract
Background: Few studies have examined patterns of specific sleep problems among individuals with osteoarthritis
(OA). The primary objective of this study was to examine prevalence of symptoms of insomnia and obstructive sleep
apnea (OSA) among Veterans with OA. Secondary objectives were to assess proportions of individuals with insomnia
and OSA symptoms who may have been undiagnosed and to examine Veterans’ characteristics associated with
insomnia and OSA symptoms.
Methods: Veterans (n = 300) enrolled in a clinical trial completed the Insomnia Severity Index (ISI) and the Berlin
Questionnaire (BQ) at baseline; proportions of participants with symptoms consistent with insomnia and OSA were
calculated, using standard cut-offs for ISI and BQ. For Veterans with insomnia and OSA symptoms, electronic medical
records were searched to identify whether there was a diagnosis code for these conditions. Multivariable linear (ISI) and
logistic (BQ) regression models examined associations of the following characteristics with symptoms of insomnia and
OSA: age, gender, race, self-reported general health, body mass index (BMI), diagnosis of post-traumatic stress disorder
(PTSD), pain severity, depressive symptoms, number of joints with arthritis symptoms and opioid use.
Results: Symptoms consistent with insomnia and OSA were found in 53 and 66% of this sample, respectively. Among
participants screening positive for insomnia and OSA, diagnosis codes for these disorders were present in the electronic
medical record for 22 and 51%, respectively. Characteristics associated with insomnia were lower age (β (SE) = − 0.09 (0.
04), 95% confidence interval [CI] = − 0.16, − 0.02), having a PTSD diagnosis (β (SE) = 1.68 (0.73), CI = 0.25, 3.11), greater
pain severity (β (SE) = 0.36 (0.09), CI = 0.17, 0.55), and greater depressive symptoms (β (SE) = 0.84 (0.07), CI = 0.70, 0.98).
Characteristics associated with OSA were higher BMI (odds ratio [OR] = 1.13, CI = 1.06, 1.21), greater depressive symptoms
(OR = 1.12, CI = 1.05, 1.20), and opioid use (OR = 0.51, CI = 0.26, 0.99).
Conclusions: Insomnia and OSA symptoms were very common in Veterans with OA, and a substantial proportion of
individuals with symptoms may have been undiagnosed. Characteristics associated with insomnia and OSA symptoms
were consistent with prior studies.
Trial registration: NCT01130740.
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Background
There is increasing recognition that sleep disturbance is a
common comorbidity among individuals with osteoarthritis
(OA) [1–4]. Previous studies suggest that at least half of pa-
tients with OA report significant sleep disturbance [4–6],
with some studies indicating the prevalence may be as high
as 70% [1, 7]. Common sleep disturbances include insom-
nia and obstructive sleep apnea (OSA). Insomnia is marked
by difficulty falling asleep, staying asleep, or waking too
early, and these difficulties may contribute to daytime im-
pairment. OSA is characterized by brief cessations in
breathing which cause sleep to be fragmented and non-
restorative. Sleep problems can have a negative impact on
many outcomes, including psychological health, quality of
life, and cardiovascular morbidity and mortality [8, 9].
Among patients with OA, sleep problems are also associ-
ated with greater pain severity [4]. This relationship is likely
a reciprocal one; in some studies sleep disturbance has pre-
dicted subsequent increases in pain severity, and in others,
pain has predicted subsequent sleep disturbance [10].
Few studies have examined factors associated with
sleep problems among patients with OA [1, 6]. Prior
findings suggest that in addition to greater pain se-
verity, other factors associated with worse sleep qual-
ity include: a greater number of arthritic joints,
depression, poor overall health, reduced physical
function, less social support, and less education [1,
6]. These studies evaluated overall sleep quality, but
interestingly, there has been very little study of the
prevalence of OSA or factors associated with OSA
among patients with OA. The prevalence of OSA is
elevated in patients with other rheumatic conditions
[11], and because many patients with OA are over-
weight or obese – a main risk factor for OSA – it
seems likely that rates would be elevated among
these patients as well. In one study of 254 patients
awaiting hip or knee arthroplasty, 6.7% of patients
had OSA based on polysomnography (overnight sleep
study). Importantly, the majority of these cases were
undiagnosed. A recent analysis of a population-based
cohort of men did not find links between OSA and
the presence of musculoskeletal joint pain or the
number of painful joints, although OA diagnosis was
not specifically assessed [12]. However, in a study of
patients referred for polysomnography, there was a
strong association between OSA severity and OA se-
verity, independent of body mass index [13]. The pri-
mary objective of this study was to examine the
prevalence of OSA and insomnia symptoms among
individuals with hip and knee OA. Secondary objec-
tives were to: 1) examine participant characteristics
associated with OSA and insomnia symptoms, 2) as-
sess proportions of individuals with OSA and insom-
nia symptoms who may have been undiagnosed
(based on information in the electronic medical rec-
ord), 3) examine participant characteristics associated
with under-diagnosis.
Methods
Study design
Data for these cross-sectional analyses were from
baseline assessments collected in the study of Patient
and Provider Interventions for Managing Osteoarth-
ritis in Primary Care (PRIMO). Details of this study
are described elsewhere [14, 15]. Briefly, this was a
cluster-randomized controlled trial, with primary care
providers (PCPs) assigned to two study arms: OA
Intervention and Usual Care control. The institutional
review board of the Department of Veterans Affairs
HealthCare System in Durham, NC (DVAHCS) ap-
proved this study. All procedures performed were in
accordance with the ethical standards of the institu-
tional research committee and with the 1964 Helsinki
declaration and its later amendments. Written in-
formed consent was obtained from all participants.
Participants
Participants (N = 300) were patients at Durham VA
Medical Center who had symptomatic hip OA (based
on radiographic evidence in the electronic medical
record) and/or symptomatic knee OA (based on
radiographic evidence in the electronic medical rec-
ord or meeting American College of Rheumatology
clinical criteria) [16]. Participants were also over-
weight or obese (body mass index (BMI) ≥ 25) and
not currently meeting weekly physical activity guide-
lines set forth by the Department of Health and Hu-
man Services (DHHS) [17]. Additional information
regarding exclusion criteria and recruitment pro-
cesses are provided elsewhere [14].
Measures
Insomnia
Insomnia symptoms were measured with the Insom-
nia Severity Index (ISI). The scale content corre-
sponds to DSM-IV criteria for insomnia and
measures respondents’ perceptions of symptoms dur-
ing the past 2 weeks. Scores were analyzed on a con-
tinuous scale with higher scores indicating greater
insomnia symptom severity. In addition, a dichotom-
ous indicator of symptoms consistent with insomnia
was calculated, based on a score greater than 10 on
the 0–28 scale [18].
Sleep apnea
OSA risk was assessed using the Berlin Questionnaire
(BQ) [19], an11-item measure based on frequency
and intensity of snoring, frequency of daytime
Taylor et al. BMC Musculoskeletal Disorders  (2018) 19:79 Page 2 of 8
sleepiness or fatigue, and presence of obesity or
hypertension. Respondents are considered “high risk”
for OSA if they have both persistent snoring and
daytime fatigue in combination with a diagnosis of
hypertension or elevated BMI (≥30 kg/m2) [20]. The
sensitivity ranges from 76 to 84% and the specificity
ranges from 38 to 59% among individuals in the gen-
eral population. Among primary care patients, the
sensitivity ranges from 54 to 86% and the specificity
ranges from 43 to 87% [19].
Insomnia and OSA diagnoses
VA electronic medical records were reviewed to ascertain if
a diagnosis of insomnia and/or OSA had ever been
recorded for each participant. ICD-9 codes for insomnia
were 780.52, 307.42, 327.02, 327.01, 307.41, 327.09, 46.72,
327, 292.85, 291.82, 780.51 and for sleep apnea were 786.03,
327.23, 780.53, 70.57, 327.21, 327.29, 327.2, 327.27, 780.51.
Patient demographic and clinical characteristics
We identified demographic and clinical characteristics
with potential links to sleep disturbance based on prior
studies [1, 6]. We collected self-reported information on
age, sex, race/ethnicity (white vs. nonwhite), self-rated
health (excellent, very good, or good vs. fair or poor),
and number of joints with OA. Body mass index was
calculated using measured height and weight collected
at the baseline assessment.
Pain was measured using the 5-item subscale from the
Western Ontario and McMaster Universities Osteoarth-
ritis Index (WOMAC), a self-reported measure of lower
extremity pain in the previous 2 weeks [21–23]. All
items are rated on a 5-point Likert scale ranging from
“none” to “extreme”; scores range from 0 to 25, with
higher scores indicating worse symptoms. Depressive
symptoms were assessed with the Patient Health
Questionnaire (PHQ-8), a reliable and valid measure
[24]. Participants rated the extent to which they were
bothered by a series of complaints based on the DSM-5
criteria for Major Depressive Disorder over the prior
2 weeks. Each of the 8 questions is scored as 0 (not at
all) to 3 (nearly every day), so that total scores range
from 0 to 24, with higher scores indicating greater
depressive symptom severity. PTSD diagnosis was
ascertained using a data pull to identify patients having
ever received a PTSD diagnosis based on ICD-9 coding
(code 309.81) in the electronic medical record. Opioid
use was assessed because of its potential contributions
to sleep problems. Participants were asked to bring all of
their current pain-related medications to the baseline
visit; the research assistant documented the class of each
medication, and a dichotomous variable was created to
indicate whether participants were using opioids at the
time of study entry.
Statistical analysis
Descriptive statistics, including means and standard
deviations (SD) for continuous variables and frequencies
for categorical variables, were calculated. Bivariate linear
(insomnia scores on ISI) and logistic (dichotomous OSA
risk from BQ) regression models were fit separately for
each patient characteristic variable described above. We
then fit multivariable linear (ISI) and logistic (BQ) re-
gression models including all patient characteristic vari-
ables to examine the associations of patient and clinical
characteristics with each condition. In the subgroup of
participants that met self-reported criteria for insomnia
or OSA, multivariable logistic regression models were fit
to examine the association of each patient characteristic
with the presence of ICD-9 codes for OSA or insomnia
in the VA medical record. Residual plots from models
were examined to assess normality assumptions, and
goodness of fit was examined for logistic regression
models. Linearity assumptions for the continuous covari-
ates in all models were assessed and found not to have
been violated. Data management and analyses were con-
ducted in SAS version 9.4 (SAS Institute, Cary, NC).
Results
Participants were an average age of 61.1 (SD = 9.2) years,
predominantly male (90.7%), and obese (mean BMI 33.8;
SD = 5.8). Additional participant characteristics are
shown in Table 1.
Descriptive characteristics of insomnia and OSA
Frequencies and descriptive characteristics for the ISI
and BQ and medical record diagnosis codes are pre-
sented in Fig. 1. Seventy-six percent of participants (n =
228/300) screened positive for at least one sleep disturb-
ance, including 23% screening “high risk” for sleep apnea
alone (n = 70), and 10% screening positive for insomnia
alone (n = 30). Forty-two percent (n = 128) screened
positive for both insomnia and OSA. More than half of
the sample (53%; n = 158/300) screened positive for in-
somnia, but only 22% (n = 35) of those individuals had
an ICD-9 code for insomnia in the medical record. Al-
though more than 66% of the sample (n = 198/300)
screened in the “high risk” category for OSA, only about
half of these (51%; n = 101) had an ICD-9 code for OSA
in the medical record.
Demographic and clinical factors associated with
insomnia severity
In bivariate models, higher self-reported insomnia sever-
ity was related to younger age, non-white race, poorer
self-rated health, a diagnosis of PTSD in the medical
record, higher self-reported arthritis pain, more
self-reported depressive symptoms, more joints with
arthritis, and current opioid use (Table 2). In the
Taylor et al. BMC Musculoskeletal Disorders  (2018) 19:79 Page 3 of 8
multivariable linear model, younger age (Estimate = − 0.09,
SE = 0.04, 95% Confidence Interval (CI) = − 0.16, − 0.02,
p = .01), PTSD diagnosis (Estimate = 1.68, SE = 0.73,
CI = 0.25, 3.11, p = .02), pain (Estimate = 0.36, SE = 0.10,
CI = 0.17, 0.55, p < .001), and depressive symptoms (Esti-
mate = 0.84, SE = 0.07, CI = 0.70, 0.98, p < .001), were asso-
ciated with insomnia severity (Table 2).
Demographic and clinical factors associated with OSA risk
In bivariate logistic models, the odds of high risk of
OSA were higher for younger age, fair or poor self-
rated health, higher BMI, diagnosed with PTSD,
higher self-reported arthritis pain, higher reporting of
depressive symptoms, and reporting more joints with
arthritis (Table 3). In the multivariable logistic model,
BMI (Odds ratio (OR) = 1.1, CI = 1.06, 1.21, p < .001),
depressive symptoms (OR = 1.12, CI = 1.05, 1.20,
p = .002), and opioid use (OR = 0.51, CI = 0.26, 0.99,
p = .05) were associated with high risk for OSA
(Table 3).
Demographic and clinical factors associated with
documented insomnia and OSA diagnoses
Among participants (n = 158) with a positive screen for
insomnia, none of the patient characteristics examined
in bivariate analyses (ORs < 1.48; p’s > .10) or the multi-
variable model (ORs < 1.47; p’s > .10) were associated
with the presence of a diagnosis code in the medical
record.
Among participants (N = 198) with a positive screen
for OSA, in bivariate logistic models the following
factors were associated with an OSA ICD-9 code in the
medical record: poorer self-rated health (OR = 0.46, CI =
0.26, 0.80, p = .007), higher BMI (OR = 1.08, CI = 1.03,
1.14, p = .002), a diagnosis of PTSD (OR = 2.83, CI
=1.53, 5.24, p = .001), more arthritis-related pain (OR =
1.08, CI = 1.00, 1.16, p = .05), more symptoms of depres-
sion (OR = 1.10, CI = 1.04, 1.16, p < .001), and opioid use
(OR = 2.09, CI = 1.12, 3.90, p = .02). In multivariable
models, among participants with a positive screen for
OSA (BQ “high risk”), the odds of having with a diagno-
sis code in the medical record was greater for higher
BMI (OR = 1.11, CI = 1.04,1.18, p < .001), a diagnosis of
PTSD in the medical record (OR = 2.51, CI = 1.24, 5.07,
p = .01), and more self-reported depressive symptoms
(OR = 1.08, CI = 1.00, 1.16, p = .04).
Discussion
Self-reported symptoms consistent with insomnia and
OSA were highly prevalent in this cohort, with a high
degree of overlap between those screening positive for
Fig. 1 Visual representation of frequencies of individuals screening
positive for OSA, insomnia, or both. Two individuals had missing ISI
scores and two individuals had missing BQ scores
Table 1 Participant demographic and clinical characteristics
Participant Characteristics (n = 300) M (SD)/ % (N)
Age 61.1 (9.2)
Gender
Male 91% (273)
Race
Non-Hispanic White 50% (150)
Education
Some College Education 73% (219)
Self-Rated Health
Excellent, Very Good, or Good 62% (186)
BMI 33.8 (5.9)
PTSD Diagnosis 28% (84)
WOMAC Paina 10.2 (4.0)
Depressive Symptomsb 6.8 (5.4)
# Joints with Arthritis Symptoms 6.2 (3.6)
Opioid Use 30% (88)
Years with OA Symptoms 14.5 (12.6)
Insomnia severity
ISI 11.4 (8.0)
Obstructive sleep apnea risk
High risk per BQ 66% (198)
BMI body mass index, PTSD post-traumatic stress disorder, WOMAC Western
Ontario and McMaster Universities Osteoarthritis Index, OSA obstructive
sleep apnea
aPossible Range = 0–20
bPossible Range = 0–24
2 participants are missing ISI and Berlin scores, 1 participant is missing a
WOMAC pain score, and 4 patients are missing a PHQ-8 score. 4 participants
are missing data on opioid use
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both conditions. Patient characteristics associated with
insomnia and OSA were largely consistent with prior
studies. A key finding was that many individuals with in-
somnia and OSA symptoms did not have corresponding
diagnosis codes in the medical record, potentially indi-
cating substantial under-diagnosis. This illustrates the
need for more consistent screening for insomnia and
OSA, given numerous negative consequences of un-
treated sleep problems [8, 9].
Fifty-two percent of this sample screened positive for
insomnia, which is notably higher than the estimated
prevalence of insomnia in the general population, (18%)
and in adults aged 55–64 (24%) [25]. This finding is con-
sistent with higher reported prevalence of insomnia in
Veterans in other studies, with estimates ranging from
24 to 54% [26]. Although a higher prevalence of
insomnia has also been reported in individuals with OA
(23%) compared to the general population [2], the preva-
lence in this sample was still much higher. Overall, our
results are consistent with previous studies demonstrat-
ing links of insomnia with PTSD diagnosis, pain, and de-
pressive symptoms in the general population [2, 27],
among individuals with OA (all but PTSD) [1], and in
Veterans [26, 28]. Our finding that increased age was as-
sociated with a lower likelihood of screening positive for
insomnia is consistent with prior research among Vet-
erans [28, 29], though the converse association has been
shown in multiple studies of the general population [30,
31].
The 66% prevalence of “high risk” for OSA is much
greater than the estimated prevalence of 17% among US
men aged 50–70 (which is a similar demographic to our
study sample). Veterans and individuals with OA tend to
exhibit characteristics associated with higher OSA risk,
including older age, higher BMI, and higher rates of
medical comorbidity. The majority of Veterans are also
male, and many have psychiatric comorbidities, which
are additional OSA risk factors [32, 33] Study findings
were consistent with past work showing associations of
OSA with BMI and depression, including analyses in
Veterans and patients referred for total joint arthroplasty
[34–36]. BMI-related findings underscore the import-
ance of OSA-targeted questioning when assessing sleep
concerns, as multiple analyses have failed to find associ-
ations between BMI and general assessments of sleep
quality in individuals with OA [1, 5]. An association be-
tween OSA and opioid use is also consistent with prior
literature [37].
Forty-three percent of our sample screened positive
for both insomnia and OSA. A high prevalence (39–
58%) of insomnia symptoms have been reported in indi-
viduals in the general population with OSA, and be-
tween 29 and 67% of individuals with insomnia had
symptoms consistent with high OSA risk [38]. High
rates of comorbid insomnia and OSA have also been
noted in military personnel [39] and Veterans [40], par-
ticularly in those with PTSD, who often present with
both conditions due to increased sympathetic activation
[41, 42]. Symptoms shared by both insomnia and OSA,
including fragmented sleep and daytime impairment,
may have contributed to the significant degree of screen-
ing overlap and thus, the true comorbidity in this sample
may be overestimated.
Consistent with the literature for both conditions, our
results suggest a significant gap between the presence of
insomnia and OSA symptoms and documented diagno-
ses [43]. Sleep concerns may be minimized or over-
looked in primary care visits, particularly when greater
attention is devoted to other chronic conditions.. Among
Veterans at high risk for OSA in this study, those with,
Table 2 Bivariate and Multivariable Linear Regression Models of
Insomnia (ISI) Scores
Bivariate and Multivariable Linear Regression Models of Insomnia (ISI)
Scores
Bivariate Model Multivariable Model
Estimate
(SE)
95%
CI
p Estimate
(SE)
95%
CI
p
Age −0.29
(0.05)
− 0.38,
− 0.19
<.001 −0.09
(0.04)
− 0.16,
− 0.02
.01
Gender
Male 1.34
(1.59)
−1.78,
4.46
.40 −0.20
(1.07)
−2.30,
1.89
.85
Race
Non-Hispanic
White
−3.07
(0.91)
−4.86,
−1.28
.001 −0.19
(0.65)
−1.47,
1.08
.76
Self-Rated Health
Excellent, Very
Good, or Good
−5.82
(0.89)
−7.58,
−4.07
<.001 −0.82
(0.73)
−2.26,
0.62
.26
BMI 0.11
(0.08)
−0.04,
0.27
.15 −0.06
(0.06)
−0.17,
0.06
.34
PTSD Diagnosis 5.65
(0.98)
3.73,
7.57
<.001 1.68
(0.73)
0.25,
3.11
.02
WOMAC Pain 1.05
(0.10)
0.85,
1.25
<.001 0.36
(0.10)
0.17,
0.55
<.001
Depressive Symptoms
PHQ-8 1.10
(0.06)
0.99,
1.22
.001 0.84
(0.07)
0.70,
0.98
<.001
# Joints with
Arthritis
0.49
(0.12)
0.25,
0.74
< 0.001 0.07
(0.09)
−0.11,
0.25
.44
Opioid Use 3.38
(0.99)
1.42,
5.33
< 0.001 0.18
(0.71)
−1.23,
1.58
0.81
All bivariate models had 2 missing observations. Otherwise, the unadjusted
model with the model with WOMAC Pain has 1 additional missing observation
and the model with PHQ-8 and the model with opioid use have 4 additional
missing observations. The multivariable model has 11 missing observations.
Negative scores associated with less insomnia symptoms. Higher WOMAC
scores indicate greater pain. Self-rated health was recoded into a binary
variable: excellent, very good, and good health vs. fair/poor health
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PTSD, higher BMI, and greater depressive symptoms
were more likely to have an OSA diagnosis noted in the
medical record. This higher rate of documentation in
the medical record could be due to more severe sleep
disturbance among individuals with these health condi-
tions or because physicians were more likely to screen
for or recognize sleep disturbance among individuals
with these risk factors [36].
There are some limitations to this study. First, the BQ
is not validated for diagnostic use, has a large range of
specificity, and may overestimate prevalence in an over-
weight population. Second, the use of ICD-9 codes may
have under-estimated actual physician diagnoses of in-
somnia and OSA, which may have been documented
elsewhere in the medical record. Third, we did not col-
lect patient information about prior treatment for sleep
problems (e.g., CPAP), which may have influenced
screening scale responses. Fourth, we did not collect in-
formation on self-reported PTSD symptoms and there-
fore relied on the presence of a diagnosis in the medical
record, which may not always be an accurate reflection
of symptoms. Fifth, we did not obtain de novo radio-
graphs and therefore did not have a measure of radio-
graphic OA severity. Finally, the study population
consisted of Veterans (primarily male), with BMIs ≥25,
thus, these findings may not generalize across different
populations. In particular, this was a group with higher
risk for sleep problems than the general population, and
patterns of diagnosis may differ outside of the VA
healthcare system.
Conclusions
In summary, this study found high rates of insomnia and
OSA among Veterans with OA. It is one of the first
studies to examine the prevalence of OSA among pa-
tients with OA and illustrates the importance of screen-
ing for OSA in this patient population. Results also
indicated that unrecognized insomnia and OSA may be
common. Given the potential for sleep problems to ex-
acerbate disease processes, pain, and disability, and in-
crease risks for other health problems, screening and
providing evidence-based treatment for both insomnia
and OSA should be a priority for providers working with
individuals with OA.
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